Navigation Links
Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists
Date:2/1/2012

search Center; Director, Colorectal Cancer Translational Research Program; and Chair, Ad Interim, Department of Cancer Biology. Dr. Ellis is vice-chair of the NCI Colon Cancer Task Force and serves on 8 editorial boards, including Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research. Dr. Ellis has served in leadership roles in major cancer societies including ASCO, American Association for Cancer Research, and the Society for Surgical Oncology.

Dr. Matthew Kulke is a world expert in neuroendocrine (NET) tumors. He is Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, where he leads the Carcinoid and Neuroendocrine Tumor Program. He has a leadership role in the Cancer and Leukemia Group B (CALGB) Gastrointestinal Cancer Committee, chairs the NCI NET Task Force and NCCN NET guidelines committees, and serves on the executive committee of the North American Neuroendocrine Tumor Society. Dr. Kulke has chaired multiple global pivotal studies exploring new therapies for NET.

About NKP-1339
NKP-1339 is a first-in-class small molecule anti-cancer compound that down-regulates GRP78, a known tumor survival and anti-apoptosis factor. In preclinical studies, NKP-1339 has demonstrated activity against multiple tumor types. In the Phase I trial, antitumor activity was seen against multiple cancers, including NET.

About NKP-2235
NKP-2235 is a first-in-class orally available small molecule that targets the endoplasmic reticulum with a unique pattern of cytotoxicity. NKP-2235 IND has been cleared and a Phase I trial will be initiated shortly.

NKP-1339 and NKP-2235 were discovered by Professor Bernhard Keppler, University of Vienna, Austria.

About Niiki Pharma Inc.
Niiki Pharma (www.niikipharma.com) is a development focused oncology company specializing in first-in-class
'/>"/>

SOURCE Niiki Pharma Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Results
2. Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
3. Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other Anti-Cancer Agents
4. Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
(Date:8/27/2014)... FAIRFAX, Va. , Aug. 27, 2014 ... in the legs due to buildup of fatty plaque ... expected in the aging patient population and in incidences ... Radiology offers its Lower Extremity Arterial RevascularizatioN ... Ariz. Endovascular specialists and interested residents and ...
(Date:8/27/2014)... Research and Markets  has announced the ... 2014" report to their offering. ... professional and in-depth study on the current state of ... provides a basic overview of the industry including definitions, ... market analysis is provided for the international markets including ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Pulse Oximeter Industry Report 2014 2
... 6, 2011 Agendia, an innovative molecular diagnostics ... paraffin embedded tissue technology applied to their Symphony™ ... in a paraffin embedded tissue format offers their ... development and validation found in Agendia,s breast cancer ...
... 6, 2011  TRACE released the 2011 BRIBEline United ... demands for bribes reported in specific countries.  Previous reports ... Ukraine, Russia, India and China. "The ... contribution to the prevention of bribery," said TRACE Founder ...
Cached Medicine Technology:Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue 2TRACE Releases Report on Bribe Demands in the United States 2TRACE Releases Report on Bribe Demands in the United States 3
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Latinos ... 5th, 6th and 7th at the Florida State Fair ... celebrates all Latino art and cultures from around the ... their platinum sponsor Go Smart Mobile and Univision Mobile, ... Festival is expecting an estimate of 4,000 people from ...
(Date:8/27/2014)... 27, 2014 New Jersey’s own Morgan ... Ridgewood County Club during The Barclays – and thanks ... of the tournament’s four rounds, stepped his way into ... Cross Blue Shield of New Jersey (Horizon BCBNSNJ) Walking ... Wyckoff native playing before family and friends at the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Seventy-three members ... Pharmacy (SoP) celebrated the beginning of their careers as ... Saturday, August 23. Students entering a four-year PharmD program ... care ?to welcome them into the profession as colleagues ... ceremony held at the Garrison Theater in Claremont, Calif., ...
(Date:8/27/2014)... therapy has spawned a prevalent but preventable side effect: ... according to a study by a Yale School of ... published in the Aug. 27 online issue of the ... to severe hot flashes also called vasomotor symptoms ... with VMS experience more than feeling hot; other frequently ...
(Date:8/27/2014)... Dennis Thompson HealthDay Reporter ... who has been mugged in a dark alley will likely ... a fear of being attacked. But neuroscientists working with ... memories are linked with positive and negative emotions. And in ... attached to a memory. In essence, they made once-reluctant ...
Breaking Medicine News(10 mins):Health News:Marc Anthony to Perform at "Nieves Productions" Latinos in Action Festival 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:The high cost of hot flashes: Millions in lost wages preventable 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3
... FRIDAY, March 4 (HealthDay News) -- A diet rich in foods ... stroke by 21 percent and may also lower your risk of ... include bananas and other fruits and vegetables, as well as fish, ... sweet potato and tomato paste top the list, according to the ...
... designed to assist weight loss by limiting the amount of ... It has been used for several years to treat obesity ... Clinical Obesity reveals that bariatric surgery can result in ... Aikenhead of the International Association for the Study of Obesity ...
... News)-- Men need more support before and after their child ... they were happy to attend childbirth classes for their partner,s ... and did not have a ready outlet for their own ... for a University of Gothenburg thesis by midwife Asa Premberg ...
... ALS or more popularly, Lou Gehrig,s disease, is a ... brain and spinal cord neurons, resulting in the gradual ... In a new paper, published in the ... Nature Neuroscience , a team of scientists at the ...
... , FRIDAY, March 4 (HealthDay News) -- Poor ... of people worldwide at risk for early death, a ... treatment and management in Colombia, England, Iran, Mexico, Scotland, ... of U.S. adult diabetics -- more than 16 million ...
... Professor of Molecular & Cell Biology at Boston University ... of Microbiology at Boston University School of Medicine discovered ... of gene expression. The study describing this work titled, ... Premature Transcription Termination," appears in the March 4 issue ...
Cached Medicine News:Health News:Potassium-Rich Foods May Cut Stroke, Heart Disease Risk 2Health News:Potassium-Rich Foods May Cut Stroke, Heart Disease Risk 3Health News:Study Finds Men Need More Support Before, After Child Birth 2Health News:Loss of key protein boosts neuron loss in ALS 2Health News:Diabetes Often Not Diagnosed or Treated Properly 2Health News:Novel mechanism for control of gene expression revealed 2
Open wire style 16 mm blade with a wing tip twist giving the surgeon better on-axis accessibility....
Angled upward 45 degrees for temporal approach. Open 14 mm blades....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: